CLS Investments »

Supernus Pharmaceuticals shares owned by CLS Investments

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by CLS Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $910k 20k 46.51
2026-03-31 $773k 15k 51.69
2025-12-31 $579k 12k 49.70
2025-09-30 $589k 12k 47.79
2025-06-30 $395k 13k 31.52
2025-03-31 $418k 13k 32.75

More positions owned by CLS Investments

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Ishares Tr Core S&p500 Etf (IVV)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Advisors Inner Circle Fd Ii 3edge Fixed Etf (EDGF)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Msci Total (IXUS)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for CLS Investments

Top funds holding Supernus Pharmaceuticals

BlackRock
Millennium Management
Vanguard Portfolio Management
Armistice Capital
Vanguard Capital Management
Nomura Asset Management International
Dimensional Fund Advisors
Geode Capital Management
Stephens Investment Management Group
Renaissance Technologies
Loomis, Sayles and
Citadel Advisors
Two Sigma Investments
Jennifer Ranahan
Sofinnova Ventures

View all funds holding Supernus Pharmaceuticals